FdaApplication
ANDA 084779
Identifiers
- fda_app_no: ANDA084779
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC |
| application_type | ANDA |
| approval_date | 1982-03-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | 30MG/ML | INJECTABLE;INJECTION |
1 product